Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment (Q80073132)
Jump to navigation
Jump to search
scientific article published on 15 February 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment |
scientific article published on 15 February 2007 |
Statements
Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment (English)
Peter Rosenberg
Hanna Urwitz
Anders Johannesson
Anne-Marie Ros
Johan Lindholm
Nils Kinnman
Rolf Hultcrantz
15 February 2007